Enzyme Fragment Complementation Platform

Enzyme Fragment Complementation Platform
Version:
20832

File Name/Number:
20832

Year:
2018

Advance your therapeutic drug screening and development programs with Enzyme Fragment Complementation (EFC) assay platform technology to get functionally relevant data. The patented EFC platform is a homogeneous detection technology that enables drug discovery researchers to measure and rank ligand potencies, perform functional screens, quantify ligand levels, identify novel compounds, and much more. Discover how EFC technology can progress your programs.